Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2

View ORCID ProfileLisa A. Cosimi, Christina Kelly, Samantha Esposito, Scott Seitz, Cole Sher-Jan, Jacquelyn Turcinovic, Kelley Friedman, Michael Nashed, Jesse Souweine, Nicholas Fitzgerald, Stacey Gabriel, John H. Connor, View ORCID ProfileDeborah Hung
doi: https://doi.org/10.1101/2022.03.03.22271766
Lisa A. Cosimi
1Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, MA, USA 02115
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa A. Cosimi
  • For correspondence: lcosimi{at}bwh.harvard.edu dhung{at}broadinstitute.org
Christina Kelly
1Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, MA, USA 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Esposito
1Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, MA, USA 02115
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Seitz
2National Emerging Infectious Diseases Laboratories, Boston, MA, USA 02118
3Department of Microbiology, Boston University School of Medicine, Boston, MA, USA 02218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cole Sher-Jan
2National Emerging Infectious Diseases Laboratories, Boston, MA, USA 02118
3Department of Microbiology, Boston University School of Medicine, Boston, MA, USA 02218
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacquelyn Turcinovic
2National Emerging Infectious Diseases Laboratories, Boston, MA, USA 02118
4Bioinformatics Program, Boston University, Boston, MA, USA 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelley Friedman
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Nashed
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesse Souweine
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Fitzgerald
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Gabriel
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H. Connor
2National Emerging Infectious Diseases Laboratories, Boston, MA, USA 02118
3Department of Microbiology, Boston University School of Medicine, Boston, MA, USA 02218
4Bioinformatics Program, Boston University, Boston, MA, USA 02215
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Hung
5The Broad Institute of MIT and Harvard, Cambridge, MA, USA 02142
6Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA UA 02115
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deborah Hung
  • For correspondence: lcosimi{at}bwh.harvard.edu dhung{at}broadinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Recent CDC COVID-19 isolation guidance for non-immunocompromised individuals with asymptomatic or mild infection allows ending isolation after 5 days if asymptomatic or afebrile with improving symptoms. The role of rapid antigen testing in further characterizing the risk of viral transmission to others is unclear.

Objective Understand rates of rapid antigen test (RAT) positivity after day 5 from a positive COVID-19 test and the relationship of this result to symptoms and viral culture.

Design In this single center, observational cohort study, ambulatory individuals newly testing SARS-CoV-2 positive completed daily symptom logs, and RAT self-testing starting day 6 until negative. Anterior nasal and oral swabs were collected on a subset for viral culture.

Main Outcomes and Measures Day 6 SARS-CoV-2 RAT result, symptoms and viral culture.

Results 40 individuals enrolled between January 5 and February 11, 2022 with a mean age of 32 years (range 22 to 57). 23 (58%) were women and 17 (42%) men. All were vaccinated. 33 (83%) were symptomatic. Ten (25%) tested RAT negative on day 6. 61 of 90 (68%) RATs performed on asymptomatic individuals after day 5 were positive. Day 6 viral cultures were positive in 6 (35%) of 17 individuals. A negative RAT or being asymptomatic on day 6 were 100% and 78% predictive respectively for negative culture, while improving symptoms was 69% predictive. A positive RAT was 50% predictive of positive culture.

Conclusion and Relevance RATs are suboptimal in predicting viral culture results on day 6. Use of routine RATs to guide end of COVID-19 isolation could result in significant numbers of culture negative, potentially non-infectious individuals undergoing prolonged isolation. However, a negative RAT was highly predictive of being culture negative. Complete absence of symptoms was inferior to a negative RAT in predicting a negative culture result, but performed better than improving symptoms. If a positive viral culture is a proxy for infectiousness, these data may help further refine a safer strategy for ending isolation.

Competing Interest Statement

D.T.H. is a founder, consultant to, equity holder in, and inventor of technology licensed to Sherlock Biosciences and serves on the Scientific Advisory Board for Proof Diagnostics, both infectious disease diagnostic companies. Neither technologies were used in this work.

Funding Statement

Costs were covered by operating funds of the Broad Institute of MIT and Harvard.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The IRB of Mass General Brigham gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 06, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2
Lisa A. Cosimi, Christina Kelly, Samantha Esposito, Scott Seitz, Cole Sher-Jan, Jacquelyn Turcinovic, Kelley Friedman, Michael Nashed, Jesse Souweine, Nicholas Fitzgerald, Stacey Gabriel, John H. Connor, Deborah Hung
medRxiv 2022.03.03.22271766; doi: https://doi.org/10.1101/2022.03.03.22271766
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2
Lisa A. Cosimi, Christina Kelly, Samantha Esposito, Scott Seitz, Cole Sher-Jan, Jacquelyn Turcinovic, Kelley Friedman, Michael Nashed, Jesse Souweine, Nicholas Fitzgerald, Stacey Gabriel, John H. Connor, Deborah Hung
medRxiv 2022.03.03.22271766; doi: https://doi.org/10.1101/2022.03.03.22271766

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3296)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (524)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7507)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)